Takeda Pharmaceuticals says it is confident in its type 2 diabetes medication Actos despite studies that show the drug puts users at risk for bladder cancer. The drug company issued a statement following a newly published study that backed up bladder cancer risks brought to light in an earlier study. The new study involved data from more than 115,000 people who were treated with diabetes drugs from 1988 to 2009. Overall, 470 people were diagnosed with bladder cancer during about 4 ½ years of follow up. Diabetics treated with Actos had an 83 percent increased risk of bladder cancer than ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.